Dermal regeneration via autologous extracellular matrix formation

Dermal regeneration via autologous extracellular matrix formation is a therapeutic tissue engineering approach in which a patient's own cells (often fibroblasts, keratinocytes, and occasionally stem cells) are used to generate new extracellular matrix (ECM) in situ or ex vivo, to serve as a biological scaffold for skin and soft tissue repair in wounds and burns. The autologous ECM provides structural and biochemical cues that promote cell proliferation, migration, angiogenesis, and tissue integration while reducing immune rejection risk. This process is facilitated by key ECM proteins such as collagen and fibronectin, and may be combined with stem cell therapy or exosome delivery to further enhance wound healing outcomes. As a process and not a discrete molecular entity, it is not a “therapeutic target” in the traditional pharmacological sense, but rather a platform for regenerative interventions.

Other names

Autologous extracellular matrix-mediated dermal regenerationAutologous ECM dermal regenerationECM-based skin regenerationECM-assisted wound healingAutologous decellularized extracellular matrix (aECM) for skin

Provides a biological scaffold supporting cell attachment and proliferation. Enhances collagen and ECM component synthesis at wound site. Promotes neovascularization by supporting endothelial migration and vessel formation. Modulates inflammation by promoting beneficial (M2) macrophage polarization and reducing chronic inflammation.